PROSPR 2 Publications

According to PubMed, the publications listed below were funded at least in part by one or more of the following PROSPR 2 grants: U24CA221936 (PROSPR Coordinating Center), UM1CA221939 (Lung PROSPR Research Center – LOTUS), UM1CA221940 (Cervical PROSPR Research Center – METRICS), UM1CA222035 (Colorectal PROSPR Research Center – PRECISE).

Balachandra S, Kusin SB, Lee R, Blackwell JM, Tiro JA, Cowell LG, et al. Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis. Cancer. 2021;127(6):850-64. Epub 2020/12/04. doi: 10.1002/cncr.33221. [View AbstractExternal Web Site Policy]

Burger EA, Jansen EE, Killen J, Kok IM, Smith MA, Sy S, et al. Impact of COVID-19-related care disruptions on cervical cancer screening in the United States. J Med Screen. 2021 Jun;28(2):213-216. doi: 10.1177/09691413211001097. Epub 2021 Mar 17. [View AbstractExternal Web Site Policy]

Burnett-Hartman AN, Lee JK, Demb J, Gupta S. An Update on the Epidemiology, Molecular Characterization, Diagnosis, and Screening Strategies for Early-Onset Colorectal Cancer. Gastroenterology. 2021;160(4):1041-9. Epub 2021/01/09. doi: 10.1053/j.gastro.2020.12.068. [View AbstractExternal Web Site Policy]

Burnett-Hartman AN, Wiener RS. Lessons Learned to Promote Lung Cancer Screening and Preempt Worsening Lung Cancer Disparities. Am J Respir Crit Care Med. 2020;201(8):892-3. Epub 2020/01/07. doi: 10.1164/rccm.201912-2398ED. [View AbstractExternal Web Site Policy]

Carroll NM, Burnett-Hartman AN, Joyce CA, Kinnard W, Harker EJ, Hall V, et al. Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance. J Gen Intern Med. 2020;35(4):1143-52. Epub 2020/01/25. doi: 10.1007/s11606-019-05539-w. [View AbstractExternal Web Site Policy]

Castanon A, Kamineni A, Elfström KM, Lim AWW, Sasieni P. Exposure Definition in Case-Control Studies of Cervical Cancer Screening: A Systematic Literature Review. Cancer Epidemiol Biomarkers Prev. 2021 Sep 14. doi: 10.1158/1055-9965.EPI-21-0376. Epub ahead of print. [View AbstractExternal Web Site Policy]

Corley DA, Sedki M, Ritzwoller DP, Greenlee RT, Neslund-Dudas C, Rendle KA, et al. Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute's PROSPR Consortium. Gastroenterology. 2021;160(4):999-1002. Epub 2020/10/24. doi: 10.1053/j.gastro.2020.10.030. [View AbstractExternal Web Site Policy]

Croswell JM, Corley DA, Lafata JE, Haas JS, Inadomi JM, Kamineni A, et al. Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond. Prev Med. 2021;151:106595. Epub 2021/07/05. doi: 10.1016/j.ypmed.2021.106595. [View AbstractExternal Web Site Policy]

Feldman S, Cook E, Davis M, Gershman ST, Hanchate A, Haas JS, et al. Cervical Cancer Incidence Among Elderly Women in Massachusetts Compared With Younger Women. J Low Genit Tract Dis. 2018;22(4):314-7. Epub 2018/09/27. doi: 10.1097/lgt.0000000000000435. [View AbstractExternal Web Site Policy]

Feldman S, Haas JS. How the Coronavirus Disease-2019 May Improve Care: Rethinking Cervical Cancer Prevention. J Natl Cancer Inst. 2021;113(6):662-4. Epub 2020/07/02. doi: 10.1093/jnci/djaa089. [View AbstractExternal Web Site Policy]

Ghai NR, Jensen CD, Merchant SA, Schottinger JE, Lee JK, Chubak J, et al. Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems. Cancer Prev Res (Phila). 2020;13(11):947-58. Epub 2020/07/17. doi: 10.1158/1940-6207.Capr-20-0109. [View AbstractExternal Web Site Policy]

Kamineni A, Tiro JA, Beaber EF, Silverberg MJ, Wheeler CM, Chao CR, et al. Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort. Int J Cancer. 2019;144(6):1460-73. Epub 2018/10/26. doi: 10.1002/ijc.31940. [View AbstractExternal Web Site Policy]

Lee CI, Houssami N, Elmore JG, Buist DSM. Pathways to breast cancer screening artificial intelligence algorithm validation. Breast (Edinburgh, Scotland). 2020;52:146-9. Epub 2019/09/22. doi: 10.1016/j.breast.2019.09.005. [View AbstractExternal Web Site Policy]

Lee JK, Jensen CD, Levin TR, Doubeni CA, Zauber AG, Chubak J, et al. Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 2020;158(4):884-94.e5. Epub 2019/10/08. doi: 10.1053/j.gastro.2019.09.039. [View AbstractExternal Web Site Policy]

Li D, Udaltsova N, Layefsky E, Doan C, Corley DA. Natural Language Processing for the Accurate Identification of Colorectal Cancer Mismatch Repair Status in Lynch Syndrome Screening. Clin Gastroenterol Hepatol. 2021;19(3):610-2.e1. Epub 2020/02/10. doi: 10.1016/j.cgh.2020.01.040. [View AbstractExternal Web Site Policy]

Ma C, Teriaky A, Sheh S, Forbes N, Heitman SJ, Jue TL, et al. Morbidity and Mortality After Surgery for Nonmalignant Colorectal Polyps: A 10-Year Nationwide Analysis. Am J Gastroenterol. 2019;114(11):1802-10. Epub 2019/10/22. doi: 10.14309/ajg.0000000000000407. [View AbstractExternal Web Site Policy]

Marcondes FO, Cheng D, Warner ET, Kamran SC, Haas JS. The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: A large U.S. academic center analysis. Prev Med. 2021;151:106640. Epub 2021/07/05. doi: 10.1016 j.ypmed.2021.106640. [View AbstractExternal Web Site Policy]

Mazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC, et al. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest. 2020;158(1):406-15. Epub 2020/04/27. doi: 10.1016/j.chest.2020.04.020. [View AbstractExternal Web Site Policy]

Murphy CC, Halm EA, Skinner CS, Balasubramanian BA, Singal AG. Challenges and Approaches to Measuring Repeat Fecal Immunochemical Test for Colorectal Cancer Screening. Cancer Epidemiol Biomarkers Prev. 2020;29(8):1557-63. Epub 2020/05/28. doi: 10.1158/1055-9965.Epi-20-0230. [View AbstractExternal Web Site Policy]

Pruitt SL, Werner CL, Borton EK, Sanders JM, Balasubramanian BA, Barnes A, et al. Cervical Cancer Burden and Opportunities for Prevention in a Safety-Net Healthcare System. Cancer Epidemiol Biomarkers Prev. 2018;27(12):1398-406. Epub 2018/09/07. doi: 10.1158/1055-9965.Epi-17-0912. [View AbstractExternal Web Site Policy]

Puricelli Perin DM, Elfström KM, Bulliard JL, Burón A, Campbell C, Flugelman AA, et al. Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey. Prev Med. 2021;151:106642. Epub 2021/07/05. doi: 10.1016/j.ypmed.2021.106642. [View AbstractExternal Web Site Policy]

Rendle KA, Burnett-Hartman AN, Neslund-Dudas C, Greenlee RT, Honda S, Elston Lafata J, et al. Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium. Cancer Prev Res (Phila). 2020;13(2):129-36. Epub 2019/12/25. doi: 10.1158/1940-6207.Capr-19-0378. [View AbstractExternal Web Site Policy]

Robbins EC, Wooldrage K, Stenson I, Pack K, Duffy S, Weller D, et al. Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study. Endoscopy. 2021;53(4):402-10. Epub 2020/08/20. doi: 10.1055/a-1217-0155. [View AbstractExternal Web Site Policy]

Rodriguez SA, Higashi RT, Betts AC, Ortiz C, Tiro JA, Luque AE, et al. Anal Cancer and Anal Cancer Screening Knowledge, Attitudes, and Perceived Risk Among Women Living With HIV. J Low Genit Tract Dis. 2021;25(1):43-7. Epub 2020/11/06. doi: 10.1097/lgt.0000000000000578. [View AbstractExternal Web Site Policy]

Selby K, Jensen CD, Lee JK, Doubeni CA, Schottinger JE, Zhao WK, et al. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study. Ann Intern Med. 2018;169(7):439-47. Epub 2018/09/23. doi: 10.7326/m18-0244. [View AbstractExternal Web Site Policy]

Selby K, Jensen CD, Levin TR, Lee JK, Schottinger JE, Zhao WK, et al. Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing. Clin Gastroenterol Hepatol. 2020. Epub 2020/10/04. doi: 10.1016/j.cgh.2020.09.042. [View AbstractExternal Web Site Policy]

Zheng Y, Corley DA, Doubeni C, Halm E, Shortreed SM, Barlow WE, et al. ANALYSES OF PREVENTIVE CARE MEASURES WITH INCOMPLETE HISTORICAL DATA IN ELECTRONIC MEDICAL RECORDS: AN EXAMPLE FROM COLORECTAL CANCER SCREENING. Ann Appl Stat. 2020 Jun;14(2):1030-1044. doi: 10.1214/20-aoas1342. Epub 2020 Jun 29. [View AbstractExternal Web Site Policy]

Last Updated: 16 Nov, 2021